DRKS00028931招募中不适用
A registry to collect characteristics and outcomes from patients with solid tumors profiled with a next-generation sequencing test (WAYFIND-R) - WAYFIND-R, MX39897
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •The registry population will include adult patients who are diagnosed with solid tumor cancers (at
- •any anatomical location) and at any stage of the disease. Both male and female patients will be
- •included in this registry.
- •Patients must meet the following criteria for enrolment in this registry:
- •- Patient is an adult (according to age of majority as defined by local regulations)
- •- Patient is currently diagnosed with any type of solid tumor cancer, at any stage of the
- •disease, at the enrolment date (informed consent date)
- •- Patient has undergone NGS testing, no longer than 3 months prior to the enrolment date,
- •irrespective of the availability of test results
- •- Informed consent has been obtained from the patient or legally authorized representative,
- •as per local regulations
排除标准
- •Patients who meet the below exclusion criterion at the time of enrolment will not be enrolled in
- •this registry:
- •- Patient has a prior or current diagnosis of hematological malignancy
研究者
相似试验
招募中
不适用
A Registry Study to collect characteristics and outcomes from patients with Solid Tumors.CTRI/2022/09/046041F HoffmannLa Roche Ltd
终止
不适用
A data and sample collection study for patients with diffuse large B-cell lymphomaDiffuse large B-cell lymphomaCancerISRCTN17717066Clatterbridge Cancer Centre NHS Foundation Trust
进行中（未招募）
不适用
An observational registry study on the use of ENCRUSO RAL- Everolimus eluting stent in indian populatioCTRI/2022/03/040921ano Therapeutics Private Limited
已完成
不适用
Registry on Vertigo Patients in IndiaCTRI/2016/01/006500Abbott India Limited1,500
招募中
不适用
Registry to collect clinical data on the effect and symptom control of electrochemotherapy for head and neck tumorsMalignant neoplasm of the oral cavity, oropharynx, hypopharynx, larynxrecurrent, metastatic or primary cancer of the head and neck (histology of any type)C14.8C10.8C32.8C13.8D23.9Overlapping lesion of lip, oral cavity and pharynxOverlapping lesion of oropharynxOverlapping lesion of larynxOverlapping lesion of hypopharynxSkin, unspecifiedDRKS00034205niversitätsklinikum Jena, Klinik für Hals-, Nasen- und Ohrenheilkunde150